CLINICAL_TRIALS trial_result · 2017-02-23

Clinical Trial Update: A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma [Phase 1]

Phase 1 pharmacokinetics study of MEDI9929 (AMG 157) in adolescents with mild to moderate asthma has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: MedImmune LLC | Conditions: Asthma | Phase 1 | Status: COMPLETED | Results posted: 2017-02-23